ECSP961719A - DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO - Google Patents

DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO

Info

Publication number
ECSP961719A
ECSP961719A ECSP961719A ECSP961719A EC SP961719 A ECSP961719 A EC SP961719A EC SP961719 A ECSP961719 A EC SP961719A EC SP961719 A ECSP961719 A EC SP961719A
Authority
EC
Ecuador
Prior art keywords
derivatives
hidroxamico
sulfonil
aril
acid
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Anthony Daniel Piscopio
James P Rizzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961719 priority Critical patent/ECSP961719A/en
Publication of ECSP961719A publication Critical patent/ECSP961719A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se refiere a derivados del ácido arilsulfonil hidroxámico que son inhibidores de metaloproteinasas de la matriz o de la producción del factor de necrosis de tumor (a partir de aquí denominado TNF) y como tales son útiles en el tratamiento de un transtorno seleccionado entre el grupo formado por artritis, cáncer, ulceración de tejidos, reestenosis, enfermedad periodontal, epidermólisis vesicular, escleritis y otras enfermedades caracterizadas por actividad de metaloproteinasa en la matriz, asi como SIDA, septicemia, choque séptico y otras enfermedades que impliquen la producción de TNF.This invention relates to arylsulfonyl hydroxamic acid derivatives that are inhibitors of matrix metalloproteinases or of the production of tumor necrosis factor (hereinafter called TNF) and as such are useful in the treatment of a disorder selected from the group formed by arthritis, cancer, tissue ulceration, restenosis, periodontal disease, vesicular epidermolysis, scleritis and other diseases characterized by metalloproteinase activity in the womb, as well as AIDS, septicemia, septic shock and other diseases that involve the production of TNF.

ECSP961719 1996-04-12 1996-04-12 DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO ECSP961719A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961719 ECSP961719A (en) 1996-04-12 1996-04-12 DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961719 ECSP961719A (en) 1996-04-12 1996-04-12 DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO

Publications (1)

Publication Number Publication Date
ECSP961719A true ECSP961719A (en) 1997-09-09

Family

ID=42042449

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961719 ECSP961719A (en) 1996-04-12 1996-04-12 DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO

Country Status (1)

Country Link
EC (1) ECSP961719A (en)

Similar Documents

Publication Publication Date Title
ES2153031T3 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF MMP AND TNF.
ES2169794T3 (en) ARILSULFONYLAMINE HYDROXAMIC ACID DERIVATIVES.
PA8456801A1 (en) DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS
UY24880A1 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES
EP0818442A3 (en) Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
UY27159A1 (en) MATRIX METALLOPROTEINASE INHIBITORS BASED ON FUSED PYRIMIDINS
GT199800025A (en) ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES.
BR9714266A (en) Cyclic sulfone derivatives.
UY27154A1 (en) MATRIX METALOPROTEINASE INHIBITING PYRIMIDINS
AR008260A1 (en) MATRICIAL METALOPROTEASE INHIBITOR COMPOUNDS BASED ON PHOSPHINATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
YU21702A (en) Substituted indoles for modulating nfkb activity
UY27155A1 (en) METALOPROTEINASE BENZOTIADIAZINE INHIBITORS OF THE MATRIX
MX9400276A (en) ARILSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS.
PT738107E (en) INHIBITORS OF FATTY ACUTE SYNTHESIS AS ANTIMICROBIAL AGENTS
BRPI0414544A (en) 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
ES2092113T3 (en) FLUOROALCOXYBENCILAMINE DERIVATIVES OF HETEROCICLES CONTAINING NITROGEN.
CA2391098A1 (en) Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
NO20000784L (en) Novel aggrecanase inhibitors and matrix metalloproteinases for the treatment of arthritis
MXPA03004347A (en) Novel imidazole derivatives, production method thereof and use thereof.
BRPI0406823A (en) Amide and Ester Inhibitors of Matrix Metalloproteinases
ECSP961719A (en) DERIVATIVES OF ACID ARIL SULFONIL HIDROXAMICO
ATE402694T1 (en) USE OF 1-PHENYL-3-DIMETHYLAMINO-PROPANE COMPOUNDS FOR THE THERAPY OF URINARY INCONTINENCE
BR0311385B1 (en) oxatinacarboxamides, their preparation process and their use, agent and their preparation process, as well as process for combating unwanted microorganisms
CO4700438A1 (en) DERIVATIVES OF ARYLSULPHONYL HYDROXAMIC ACIDS WHICH ARE INHIBITORS OF MATRIX METALOPROTEINASES OR THE PRODUCTION OF TUMOR NECROSIS FACTOR
AR003417A1 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES AND COMPOSITION CONTAINING THEM.